COVID-19: Implications for Patients With CLL

Keep abreast of ongoing developments in providing optimal care for patients with CLL during COVID-19 and evolving research into countering COVID-19&ndash associated inflammatory cytokine production! Get expert perspectives on emerging data with focused commentaries an FAQ module and a &ldquo living&rdquo slideset regularly updated to incorporate the most important clinical findings on CLL and COVID-19.

Share

Program Content

Activities

Acalabrutinib in COVID-19
Hot Off the Press: New Data on the Use of Acalabrutinib to Manage Patients With Severe COVID-19
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2020

Expires: June 15, 2021

Telemedicine for CLL
Telemedicine: Managing Patients With CLL During the COVID-19 Pandemic
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 13, 2020

Expires: July 12, 2021

CLL COVID: Therapy Choice
How I Have Been Managing My Patients With CLL During the COVID-19 Pandemic in NYC: Selecting Therapy to Minimize Risk
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 11, 2020

Expires: August 10, 2021

CLL Patient Counseling
Counseling Patients With CLL on Mental and Physical Health During COVID-19
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 31, 2020

Expires: August 30, 2021

CLL COVID: Therapy Issues
My Take on Key Therapy Issues for Patients With CLL During COVID-19
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 14, 2020

Expires: September 13, 2021

Changes in CLL Practice
Six Months Later: How COVID-19 Has Changed My Management of CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 30, 2020

Expires: September 29, 2021

CLL Cases
How I Managed 2 Challenging Patients With CLL During the COVID-19 Pandemic
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 13, 2020

Expires: November 12, 2021

CLL COVID: Updates
Updates on BTKi Therapy for COVID-19 and Considerations for Patients With CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2020

Expires: December 15, 2021

Activities

COVID-19 and CLL Slides
COVID-19 Implications for Patients with CLL: Living Slideset
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 02, 2020

Expires: July 01, 2021

Activities

FAQ: CLL and COVID-19
Expert Answers to Frequently Asked Questions About Chronic Lymphocytic Leukemia and COVID-19
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

Faculty

cover img faculity

Jacqueline Barrientos, MD, MS

Associate Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Attending Physician
Division of Hematology/Oncology
Northwell Health System
Lake Success, New York

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

cover img faculity

Brian Koffman, MDCM

PCN Content Reviewer
Medical Director, CLL Society Inc.
Partner, St Jude Heritage Medical Group
Diamond Bar, California
Clinical Professor (Retired)
Department of Family Medicine
Keck School of Medicine, USC Family Practice
Los Angeles, California

cover img faculity

Nicole Lamanna, MD

Associate Professor
Leukemia Service
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York-Presbyterian/Columbia University Medical Center
New York, New York

cover img faculity

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

cover img faculity

Jacob D. Soumerai, MD

Instructor
Attending Physician

Department of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca